Penumbra (PEN) EBITDA Margin Growth (1y) (2015 - 2026)
Penumbra (PEN) EBITDA Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -313.00 |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 58.00 |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 535.00 |
| 10 | Penumbra | 12.58 Bn | 11.96 Bn | 253.41 Mn | -225.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -225.00 |
| Dec 31, 2025 | 181.00 |
| Sep 30, 2025 | 202.00 |
| Jun 30, 2025 | 3,907.00 |
| Mar 31, 2025 | 811.00 |
| Dec 31, 2024 | 125.00 |
| Sep 30, 2024 | 709.00 |
| Jun 30, 2024 | -3,388.00 |
| Mar 31, 2024 | 103.00 |
| Dec 31, 2023 | 1,012.00 |
| Sep 30, 2023 | 212.00 |
| Jun 30, 2023 | 691.00 |
| Mar 31, 2023 | 530.00 |
| Dec 31, 2022 | 2,182.00 |
| Sep 30, 2022 | -208.00 |
| Jun 30, 2022 | -566.00 |
| Mar 31, 2022 | -994.00 |
| Dec 31, 2021 | -1,859.00 |
| Sep 30, 2021 | 1,796.00 |
| Jun 30, 2021 | 2,239.00 |